Jan 7, 2024

Isomorphic Labs kicks off 2024 with two pharmaceutical collaborations

Posted by in categories: biotech/medical, robotics/AI

Eli Lilly & Novartis are entering a strategic research collaboration with Isomorphic Labs to use state-of-the-art AI technologies—including the next-gen model of #AlphaFold—to discover novel small molecule therapeutics for select biological targets.

We are reimagining the entire drug discovery process from first principles with an AI-first approach.

Leave a reply